The 20 Best Anaplastic Thyroid Cancer Doctors Near Me in Brighton, MI

Arul S. Thirumoorthi, MD FACS PE is currently a Clinical Assistant Professor in the Section of Pediatric Surgery. He is the Director of the Multi-disciplinary Pediatric Endocrine Surgery and Trauma Programs. He received his medical degree from the University of Toledo College of Medicine. He completed his General Surgery Internship and Residency at New York University. He completed an ECMO and research fellowship at Columbia University. Dr. Thirumoorthi completed his Pediatric Surgical Fellowship at Loma Linda University and complete his Surgical Critical Care Fellowship at the University of Michigan. Dr. Thirumoorthi is triple board certified in General Surgery, Pediatric Surgery, and Critical Care.Clinical Specialization:Dr. Thirumoorthi’s surgical practice encompasses all areas of general pediatric surgery and pediatric diseases of the neck, chest, and abdomen. His clinical areas of specific interest are pediatric endocrine surgery (thyroid, parathyroid and adrenal) and surgical oncology. Dr. Thirumoorthi also is also interested in pediatric trauma, critical care and ECMO. Dr. Thirumoorthi is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Fryns Syndrome, Donnai-Barrow Syndrome, Omphalocele, and Congenital Unilateral Pulmonary Hypoplasia.

Kara Mizokami-Stout, MD, MSc is an Assistant Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes. She attended medical school and internal medicine residency at the University of Colorado. She then completed her endocrinology fellowship at the University of Michigan. She joined the faculty at the University of Michigan in 2017 and has a dual appointment at the Ann Arbor VA.Dr. Mizokami-Stout’s practice focuses on type 1 diabetes, type 2 diabetes, and general endocrinology. She also conducts health services research in the field of diabetes. Dr. Mizokami is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Diabetic Neuropathy, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Graves Disease. Dr. Mizokami is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Grace Hendrix is a Pediatric Endocrinologist and a Pediatrics provider practicing medicine in Brighton, Michigan. Dr. Hendrix is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Delayed Growth, Short Stature (Growth Disorders), and Familial Short Stature (FSS). Dr. Hendrix is board certified in Pediatric Endocrinology and Pediatrics.

Nada Fanous is an Internal Medicine specialist and an Endocrinologist practicing medicine in Brighton, Michigan. Dr. Fanous is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Hashimoto Thyroiditis, and Hyperparathyroidism.

Megan R. Haymart, MD is Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan. She holds the Nancy Wigginton Endocrinology Research Professorship of Thyroid Cancer and is Director of Thyroid Cancer Research at the University of Michigan. Dr. Haymart received her medical degree at Johns Hopkins University School of Medicine and completed her internal medicine residency at Johns Hopkins Hospital. She then completed a fellowship in endocrinology, diabetes, and metabolism at the University of Wisconsin. She has been faculty at the University of Michigan since 2009.Dr. Haymart has a history of NIH-funded research focused on optimizing thyroid care delivery. She is a health services researcher who primarily studies thyroid cancer care across the disease continuum: from the diagnosis of a thyroid nodule to cancer survivorship. In recognition of her research, she received the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland (2017), the University of Michigan’s Jerome Conn Award for Research Excellence (2017), membership to American Society for Clinical Investigation (2018), the AACE Hossein Gharib Education Lectureship Award for exemplary contributions to an individual profession or area of expertise (2021), and the inaugural AACE Endocrine Care Innovation Award in recognition of her team’s outstanding body of work focused on clinical outcomes or health care delivery (2025).Dr. Haymart is actively involved in improving research infrastructure at the University of Michigan. This includes her roles as Assistant Director of Data Solutions for AI & Digital Health Innovation, faculty support for MICHR, and co-Director of Patient’s First. She also devotes time to mentoring junior faculty and trainees resulting in her receipt of the MICHR Distinguished Clinical and Translational Research Mentor Award (2021) and the Women in Thyroidology and American Thyroid Association Woman of the Year Award (2021) for promoting the advancement of women, both within the organization and field. Dr. Haymart is rated as a Distinguished provider by MediFind in the treatment of Anaplastic Thyroid Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Thyroid Nodule, Papillary Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Haymart is board certified in Endocrinology, Diabetes & Metabolism.

Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA). Dr. Esfandiari is rated as a Distinguished provider by MediFind in the treatment of Anaplastic Thyroid Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Gastric Bypass, and Thyroidectomy. Dr. Esfandiari is board certified in Endocrinology, Diabetes & Metabolism.

Mark Ealovega is a primary care provider, practicing in Internal Medicine in Brighton, Michigan. Dr. Ealovega is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Bicuspid Aortic Valve, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Familial Hypertension. Dr. Ealovega is board certified in Internal Medicine.

University of Texas Southwestern in Dallas, Texas. Her clinical practice has focused on head and neck cancer, lymphoma and hematologic malignancies, CNS malignancies, lung cancer, and breast cancer. However, she is board certified and experienced in treating all disease sites. She has clinical research experience in several disease sites as well, including head and neck cancer, glioblastoma, esophageal cancer, cutaneous lymphoma, and lung cancer. Patient care is her passion, and she enjoys working with patients on a daily basis. She is a strong believer in patient education and making sure patients understand their disease and treatment options. Based on her experience developing clinical trials at Stanford, she is developing an academic program focused on the conduct of clinical trials as well as patient and physician decision-making regarding clinical trials. Her goal is to develop tools to improve clinical trial enrollment through medical team communication as well as patient and physician education. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Pleuropulmonary Blastoma, Angiosarcoma, and Intraductal Papilloma.

Dr Joseph Evans is originally from the Chicago suburbs, and attended the University of Iowa where he graduated with a Bachelor of Science degree in Physics. He then completed the MD-PhD program at Northwestern University Feinberg School of Medicine, where his graduate studies focused on inhibitors of cell death in cancer cells. Dr Evans entered Radiation Oncology at University of Michigan where he completed Residency.Clinically, Dr Evans sees and treats patients with gynecologic cancer, including brachytherapy, spine metastases, and benign diseases treated with radiation treatment, particularly Dupuytren's disease.Dr Evans is a physician leader in the department and the Rogel Cancer Center. He works with other faculty and staff leaders on clinical operations within the department and the interface with the Cancer Center, focusing on process improvement, quality metrics, financial stewardship, and strategy. His work streamlines workflows in the Electronic Medical Record (Epic) to improve patient care, patient experience, and clinician experience. Dr. Evans is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, and Prostate Cancer. Dr. Evans is board certified in Radiation Oncology.

Dr. Dragovic attended the University of Michigan for both undergraduate and medical school, and after completing radiation oncology residency at the University of Alabama at Birmingham (UAB), he returned to Ann Arbor to join the U of M Department of Radiation Oncology faculty in 2012. Since that time, he has held several roles in the Department of Radiation Oncology, with experience in multiple of the department’s community practice affiliates as well as at the main hospital. Dr. Dragovic was chosen to lead the department’s new clinic at the Brighton Center for Specialty Care and also to represent the BCSC Cancer Center as a whole as Physician Lead. He has taken on these roles with great joy and pride as it has been both a challenge and reward being a part of building a new cancer center. Dr. Dragovic’s vision for the BCSC Cancer Center is to become more or less an extension of the University Hospital Cancer Center- providing the highest quality multidisciplinary care to patients with a wide variety of cancer diagnoses, including the availability of clinical trial enrollment for appropriate patients. Clinically, Dr. Dragovic treats all disease sites and has a specific clinical interest in head & neck cancer, lung cancer, and stereotactic body radiotherapy (SBRT). Dr. Dragovic is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Laryngeal Cancer, and Breast Cancer. Dr. Dragovic is board certified in Radiation Oncology.

Dr. Morrison is an Associate Professor in the Division of Laryngology of the Department of Otolaryngology-Head and Neck Surgery. He has a clinical practice which sub-specializes in the surgical and medical management of airway, voice, and swallowing disorders. He developed and helps direct the University of Michigan Complex Airway Intervention and Reconstruction (AIR) Program, and is an active contributing member of the North American Airway Collaborative (NoAAC), helping to drive innovation in the understanding and treatment of complex airway disorders. He is integrated into the Biomedical Engineering-Otolaryngology collaborative consortium and is a member of the Michigan Institute for Clinical and Health Research (MICHR). He serves as Director for Quality and Outcomes for the Department of Otolaryngology-Head & Neck Surgery and Medical Director for the Department of Speech Language Pathology in adult hospitals at the University of Michigan.Dr. Morrison received his medical degree from Oregon Health & Science University. He completed his post-graduate surgical training in Otolaryngology-Head and Neck Surgery at the University of Michigan during which he completed an 18-month NIH funded research fellowship in the Biomedical Engineering with a focus on 3D-printing applications in surgery, patient-specific medical device development, and cartilage tissue engineering. He then completed a fellowship in Laryngology and Complex Airway Reconstruction at the Vanderbilt Voice Center in Nashville, Tennessee.Dr. Morrison has research interests representative of his diverse training background. He has authored numerous peer-reviewed articles and book chapters and gives lectures and instructional courses nationally on airway stenosis and laryngologic disorders. He has a particular interest in the etiogenesis and treatment of idiopathic subglottic stenosis (iSGS), treatment of acute laryngotracheal injury and iatrogenic laryngotracheal stenosis, complex airway reconstruction outcomes, voice disorders and recurrent laryngeal nerve rehabilitation.He is a national expert in 3D printing in medicine and the regulatory framework and development process of medical devices and novel therapeutics. He serves as physician leadership within the Michigan Medicine IND/IDE Investigators Assistance Program (MIAP) and is active within the Clinical and Translational Science Awards (CTSA) Program and national biomedical engineering bodies such as the American Society of Manufacturing Engineers (ASME).Dr. Morrison has completed additional education and leadership experiences in patient safety and quality improvement (PS/QI) including the AAMC Teaching 4 Quality curriculum and the University of Michigan PASQUAL scholars program. He serves a number of institutional roles in PS/QI leadership, implementation, and also directs the residency PS/QI educational curriculum. Dr. Morrison is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Spasmodic Dysphonia, Tracheobronchomalacia, Acquired Tracheomalacia, Laryngectomy, and Glossectomy. Dr. Morrison is board certified in Otolaryngology-Head & Neck Surgery.

Andrew Meram is a General Surgeon and an Oral and Maxillofacial Surgeon practicing medicine in Brighton, Michigan. Dr. Meram is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Mouth Ulcers, Mouth Sores, Oral Mucous Cyst, Tissue Biopsy, and Glossectomy. Dr. Meram is currently accepting new patients.

Maria Papaleontiou, MD, is an Associate Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes, and a Research Associate Professor at the Institute of Gerontology, at the University of Michigan. Prior to starting her internal medicine residency at Saint Peter's University Hospital in New Jersey, she spent several years conducting clinical research on aging at Weill Cornell Medical College in New York City. She completed her endocrinology fellowship at the University of Michigan, where she subsequently joined the faculty in 2013. She is a recipient of Fulbright and Howard Hughes Medical Institute scholarships. Her clinical practice focuses on thyroid diseases and thyroid cancer, as well as geriatric endocrinology.Dr. Papaleontiou is also a health services researcher in the field of thyroidology and aging. Her research focuses on evaluating the risks of thyroid hormone overtreatment and misuse in older adults, understanding the role of providers and patients in thyroid hormone use and misuse and how it relates to patient outcomes in the aging population, as well as the role of age and comorbidity in thyroid cancer decision-making. Her ultimate goal is to develop tools to tailor thyroid disease treatment to older adults by translating research findings into effective strategies and interventions to improve the care of older adults and reduce patient harm. She has received funding from the National Institute on Aging, the Claude D. Pepper Older American Independence Centers, the University of Michigan Biology of Cardiovascular Aging Core and the Elizabeth Caroline Crosby Research Award. She serves on multiple national committees including at the American Thyroid Association (ATA), the Endocrine Society, the American Association of Clinical Endocrinology and the North American Society for Interventional Thyroidology. She has served as Co-Chair for the ATA’s Annual Program Committee (2021-2022), Chair of the ATA’s Women in Thyroidology (2022-2023) and Vice-Chair for AACE's Thyroid Disease State Network (2022-2023). She is an Associate Editor for Endocrine Practice, and serves on the Editorial Boards for Thyroid and BMC Endocrine Disorders. Dr. Papaleontiou is rated as an Advanced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Thyroid Nodule, Hypothyroidism, Thyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Papaleontiou is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Debbie Chen is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, and Medullary Thyroid Carcinoma.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Douyon is rated as an Advanced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Zahrae Sandouk M.D., is a Clinical Assistant Professor, board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism and a graduate from Henry Ford Hospital and Cleveland Clinic who has an interest in Diabetes mellitus, Diabetes complications, Cystic Fibrosis related Diabetes, Pituitary disorders, Prolactinoma, Hypopituitarism, Thyroid disorders, Bone and calcium disorders, Adrenal and Osteoporosis. Also the medical director of the Endocrine Testing Unity at the University of Michigan where dynamic studies are performed and is also part of the Cystic Fibrosis multidisciplinary team. Dr. Sandouk is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Type 2 Diabetes (T2D), and Thyroid Nodule. Dr. Sandouk is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Jennifer Franzese is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Franzese is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Thyroid Nodule.

Preethi Gogineni is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Gogineni is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Hyperparathyroidism, Type 1 Diabetes (T1D), Gestational Diabetes, and Osteoporosis.

Melda Ince is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Ince is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Congenital Generalized Lipodystrophy, Autosomal Dominant Hypocalcemia, Graves Disease, and Thyroid Storm.

Dr. Lynn Ang is currently a Clinical Associate Professor in the Metabolism, Endocrinology, and Diabetes Division, Internal Medicine Department at University of Michigan. Dr. Ang is one of the principle attending physicians for the Diabetes Transition Program. Dr. Ang’s clinical and research interests are in the fields of implementing optimal management of inpatient and outpatient hyperglycemia, creating protocols for inpatient hospital guidelines, identifying biomarkers to predict the development or progression of diabetic complications, detecting the earliest stages of complications to prevent progression of diseases, and developing sensitive diagnostic methods/treatment for those complications. Dr. Ang also serves as a Co-Director of Hospital Intensive Insulin Program. Dr. Ang has been actively involving in teaching internal medicine and podiatry residents, endocrinology fellows, and medical students in both ambulatory and inpatient clinical settings. She was a recipient of Goran Sundkvist Young Investigators Award for Clinical Science 2022. Dr. Ang is rated as an Experienced provider by MediFind in the treatment of Anaplastic Thyroid Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Neuropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Ang is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.